Current evidence of temozolomide and bevacizumab in treatment of gliomas
© W. S. Maney & Son Ltd 2015. Objective: This review article summarizes in vitro, in vivo, and clinical evidence pertaining to temozolomide (TMZ) and bevacizumab (BEV) efficacy and mechanism of action in gliomas.Methods: Relevant publications published before June 2013 in PubMed database were...
Saved in:
Main Authors: | Danop Nanegrungsunk, Wimrak Onchan, Nipon Chattipakorn, Siriporn C. Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84919342660&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54760 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Current evidence of temozolomide and bevacizumab in treatment of gliomas
by: Danop Nanegrungsunk, et al.
Published: (2018) -
Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
by: Danop Nanegrungsunk, et al.
Published: (2018) -
Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
by: Nanegrungsunk D., et al.
Published: (2017) -
Combined temozolomide and radiation as an initial treatment for anaplastic glioma
by: Tham, C.K., et al.
Published: (2016) -
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients
by: David A. Reardon, et al.
Published: (2018)